Key result
Adjuvant chemotherapy was associated with significantly increased long-term survival compared to no chemotherapy (27.0% vs 0%, p=0.001) in patients following surgical resection of primary cardiac sarcoma.
Why the study?
Primary cardiac sarcoma is an extremely rare disease, and this study aimed to identify prognostic factors for long-term survival.
What are the prognostic factors for long-term survival after surgical resection of primary cardiac sarcoma?
Population
17 consecutive patients treated for primary CS at two cardiac centers
Design
Two-center retrospective cohort study
Authors
Loading...
May support adjuvant chemotherapy after cardiac sarcoma resection; leaves open need for prospective validation.
Cohort (n=17)
Yes
What are the prognostic factors for long-term survival after surgical resection of primary cardiac sarcoma?
Absolute Event Rate: 27% vs 0%
p-value: p=0.001
Aboud et al. (2019) conducted a cohort in Primary cardiac sarcoma (n=17). Adjuvant chemotherapy vs. No adjuvant chemotherapy was evaluated on Long-term survival (p=0.001). Adjuvant chemotherapy was associated with significantly increased long-term survival compared to no chemotherapy (27.0% vs 0%, p=0.001) in patients following surgical resection of primary cardiac sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: